4.3 Article

2009 White Paper on Recent Issues in Regulated Bioanalysis from The 3rd Calibration and Validation Group Workshop

Journal

BIOANALYSIS
Volume 2, Issue 1, Pages 53-68

Publisher

FUTURE SCI LTD
DOI: 10.4155/BIO.09.134

Keywords

-

Funding

  1. US FDA
  2. Health Canada TPD
  3. UK MHRA
  4. European Bioanalysis Forum (EBF)
  5. Workshop sustaining sponsors: Acanthus Research
  6. Agilent Technologies
  7. Algorithme Pharma
  8. Anapharm
  9. Cantest
  10. CEDRA
  11. Chemtos
  12. Lachman Consultants
  13. MDS Pharma Services
  14. PPD
  15. Prevalere Life Sciences
  16. Synfine Research
  17. Waters
  18. Media Partner: Future Science Group

Ask authors/readers for more resources

The 3rd Calibration and Validation Group Workshop on Recent Issues in Regulated Bioanalysis was organized by the Calibration and Validation Group as a I.5-day full immersion workshop for contract research organizations, pharmaceutical companies and regulatory agencies to discuss several 'hot' topics concerning bioanalytical issues and regulatory challenges. A consensus was reached among panelists and attendees on many points regarding method validation of small molecules.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available